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THE HEROIN SOLUTION. By Arnold S. Trebach. New Haven, Conn.:
Yale University Press. 1982. Pp. xvi, 320. $24.95.
In America, only criminals take heroin. The mere possession of
heroin is criminal without exception, and so even doctors who would
use it for legitimate medical purposes cannot do so. The terribly high
black-market prices resulting from criminalization force addicts to
steal in order to buy the drug, and so America is afflicted with a second level of illegality - drug-related crime. In The Heroin Solution,
Arnold S. Trebach argues persuasively that neither of these results of
heroin's criminalization should be tolerated any longer. He concludes
that the United States, by making heroin a legal prescription drug as it
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has long been in Britain, could avoid these results by eliminating their
cause.
Much has been written on the addiction problem in the United
States, but The Heroin Solution takes a somewhat different approach
than most books on the topic. It is something of a guided tour
through Professor Trebach's extensive knowledge of the subject, with
his doubts candidly pointed out along the way to his conclusions.
Trebach is a professor at the School of Justice of The American University in Washington, D.C. In 1974, he organized the American University's Institute on Drugs, Crime, and Justice in London, and he
remains its director. In his book, he moves freely back and forth
across the Atlantic, from scholarly references to his own conversations
with drug experts, to brief surveys of scientific studies, to personal stories that sometimes border on the sensational. The reader comes away
with an appreciation of the tremendous diversity of opinion about heroin, and a massive sense of frustration at the inconclusiveness of the
scientific evidence about the drug. But by relating his own appreciation of the complexity of these issues, Trebach also imparts a sense of
the soundness of his conclusions about the problem and its possible
solutions. He suggests that those who would compare the heroin situation in England to that in the United States "must ultimately make
independent judgments based on a review of as much of the original
evidence as possible" (p. 87). This is also what he offers his readers: a
huge body of scientific and historical information and a way of interpreting it so that an approach often dismissed as preposterous looks
worthy of a very close second look.
After establishing that heroin addiction is a serious and worsening
problem in most of the world, Trebach turns to a subject seldom considered in popular discussion of heroin legalization: the medical use of
heroin to treat pain. British doctors routinely use heroin to treat burn
and heart-attack victims and, most dramatically, cancer patients. The
conventional American wisdom has been that heroin has no unique
advantage over morphine in the treatment of organic disease. The scientific results are contradictory, but Trebach presents enough subjective impressions by doctors to convince the reader that the United
States may well be sacrificing medical benefits that, in some situations
and for some patients, only heroin can provide. 1
In light of the British experience, most thoughtful commentators
would concede that there is no medical reason why heroin should be
1. In April of 1984, the House Committee on Energy and Co=erce reported favorably on a
bill that would set up a four-year trial during which heroin would be made available to certain
hospital and hospice pharmacies and during which doctors would be permitted to prescribe it for
terminally ill cancer patients only. Professor Trebach was one of eight individuals testifying on
the bill before the Subcommittee on Health and the Environment. See House Comm. on Energy
and Commerce, Report to Accompany H.R. 5290, the Compassionate Pain Relief Act, H.R.
Rep. No. 689, 98th Cong., 2d Sess. (1984).
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totally unavailable for the treatment of organic disease. Although a
few fatuous physicians can always be found who will decry the administration of heroin to terminal cancer patients because of its addictive
potential, Trebach recognizes that the truly hard questions concern
the use of heroin to treat addiction itself. It is to the differences between Britain and America in this regard that he devotes the majority
of the book.
Starting from very similar beginnings around the turn of the century, Britain and America soon took radically different approaches to
the regulation of heroin. Trebach starts by examining the development of what is usually referred to as the "British system," and his
message is that it is not a "system" at all. More accurately, it is not
the centrally-run, top-down bureaucracy that Americans accustomed
to hearing about British addict registration and socialized medicine
often expect. Instead, the traditional British approach has been to
leave the power to prescribe heroin entirely within the discretion of
individual doctors. Heroin addiction is considered more a medical
problem than a legal one, and it is for an addict's doctor to decide how
to treat him. Until recently, doctors could administer other drugs (including morphine), wean addicts with gradually diminishing doses of
heroin, or maintain them on stable doses of inexpensive, pure heroin
for the rest of their lives. 2 Although in recent years British doctors
have seemed less likely to choose to treat addicts with heroin, British
law still requires only that doctors who do prescribe heroin or cocaine
to addicts for treatment of their addiction (but not for treatment of
organic illness) be specially licensed. The British government does not
dispense drugs, and addicts have never been "registered." Until recently, private doctors wrote heroin prescriptions entirely free from
official second-guessing and the fear of prosecution. And until it was
made mandatory in 1968, doctors "notified" addicts to the Home Office only as a matter of courtesy; 3 the chief use of the information still
seems to be in compiling the most detailed and complete set of addiction statistics anywhere.
The American system, on the other hand, is a "system" in the
grandest bureaucratic tradition. From the time the Harrison Act4 was
passed in 1914 to ·restrict the use of narcotics to doctors in the course
of their professional practice, the American medical establishment has
maintained that there is no legitimate need to use heroin in the practice of medicine. Instead of fighting for the right to make private medical judgments, as did their British counterparts, most American
2. The British have always considered the "cold-turkey" sudden-withdrawal method, a hallmark of American "treatment" as early as 1926, to be inhumane. P. 91.
3. Although notification was made mandatory in 1968, it still carries no legal consequences
for the addict.
4. Harrison Narcotic Act, Pub. L. No. 63-223, 38 Stat. 785 (1914).
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doctors supported the efforts of Treasury officials5 who gradually regulated away most of the discretion American doctors had regarding the
use of heroin. Legal heroin was virtually unavailable in America after
1924, and the drug was outlawed entirely in 1956.
Trebach's meticulous argument is probably unnecessary to convince most readers that the American approach to heroin addiction
has failed. Huge expenditures on enforcement and on methadone
maintenance programs have proved only that most addicts prefer heroin to methadone and that the black market will find ways to satisfy
this demand at any cost. 6 Looking for a solution, Trebach finds that
the British approach has, at least until recent years, 7 held addiction
levels stable and largely removed the impetus to heroin-related crime.
Meanwhile, on this side of the Atlantic the growing size of federal
drug busts has been matched, perversely, only by the growing number
of heroin addicts.
Trebach's recommendation is that America follow the British
model, legalizing heroin for medical treatment and keeping the state
out of the business of deciding what is legitimate medical treatment
and what is not. As an example of this approach in America, he holds
up the Shreveport clinic of Dr. Willis Butler, who used opiates successfully to treat both organic disease and addiction from 1919 to
1923. Indeed, if it worked here until the government intervened, and
worked in Britain for over forty years, why not go back to this approach? Professor Trebach builds a compelling historical argument
for the superiority of legalization. Unfortunately, his careful research
also reveals that British practice today is changing. The legal structure there is narrowing the scope of doctors' previously unquestioned
discretion but, perhaps more significantly, British doctors are also voluntarily abandoning their previous approach in favor of a very American-looking system.
Beginning around 1960, the British addiction picture started to
change. The previously stable addict population began to grow, and
the new addicts resembled American addicts - young, deviant, and
5. The Harrison Act was passed as a tax measure in an era when federal power to regulate
was limited. Trebach notes that several writers, apparently unaccustomed to the convolutions of
constitutional interpretation, have concluded that the statute was intended by Congress "as a
revenue and record-keeping measure and nothing more," and was later used by the federal bureaucracy "for its own ends." P. 119. Trebach's careful review of the legislative history leaves
no doubt that if Congress could have simply outlawed heroin in 1914 as they did in 1956, they
would have.
6. Even authors who stop short of Trebach's radical proposals agree with his description of
the present system's shortcomings. See, e.g.• J. KAPLAN, THE HARDEST DRUG: HEROIN AND
PUBLIC POLICY (1983) (reviewed at 82 MICH. L. REV. 1032 (1984)). Kaplan concludes that
there are too many practical problems with heroin maintenance. He recognizes the poor record
methadone maintenance has had, but suggests that the answer is expanded methadone programs
with coerced attendance.
1. See text at note 8 infra.
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poor - more closely than the traditional British addict, who was often
an older person who had become addicted through medical treatment
rather than through recreational use. In response, most British doctors
were forbidden to prescribe heroin for the treatment of addiction. 8
Private doctors can still prescribe heroin for the treatment of organic
illness, and may still administer morphine, methadone, or other narcotics to addicts. But only specially licensed physicians, found almost
exclusively in drug-treatment clinics, are permitted to treat addicts
with heroin. Increased regulation, however, is by no means the only
change. Rather than use their power to continue longstanding practice, these clinic doctors have moved away from prescribing injectables
such as heroin, and instead are using oral methadone almost
exclusively.
The new British approach, like the old American approach on
which it is based, does not appear to have solved the problem. Trebach
does not suggest that this "proves" the efficacy of the approach that
worked for so long before the British discarded it. He admits that the
evidence is unclear; in fact, the chapter on Britain today is entitled
"Doubt and Uncertainty" (p. 171). As with the other controversial
issues in the book, his approach to the British change of heart is to lay
out the history of the change and survey the views on both sides of the
issue. But, for the first time in the book, Professor Trebach's approach
backfires here; as the title indicates, the reader is left dubious and uncertain. The facts are simple enough, but Trebach makes little attempt
to sort out cause from effect, or to address the sociological factors influencing the change. How much of the medical and legal attitude
shift is due to the sudden change in the type of addict showing up for
treatment? How much of the failure of the new British approach is
due to the change in legal regulations, how much to the new treatment
methods, and how much to the change in the addicts themselves? Significantly, the Shreveport clinic that serves as Trebach's model for the
future treated a clientele very different from the urban addicts who
form the majority of modern heroin addicts in America. 9 If the British/Shreveport approach does not work with these addicts, either because societal attitudes will not allow it to work or because there is
something fundamentally different about the addicts themselves, then
Professor Trebach's proposal for the future is neither politically practicable nor socially desirable.
The Heroin Solution lays a thorough groundwork for future discus8. At least one author has argued that the change came in response to the new type of addict
rather than to the increased number of addicts. See P. BEAN, THE SOCIAL CoNTROL OP DRUGS
113 (1974). For a very detailed treatment of the recent British experience, see DRUG PROBLEMS
IN BRITAIN: A REVIEW OP TEN YEARS (G. Edwards & C. Busch eds. 1981).
9. See p. 150. Recent work has shown the importance of addict type to the success of methadone-maintenance programs. See, e.g., D. BELLIS, HEROIN AND PoLmCIANS: THE FAILURE
OP PUBLIC POLICY TO CoNTROL ADDICTION IN AMERICA (1981).
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sion of heroin maintenance. It brings to the dialogue some ideas that
laymen, politicians and physicians have generally nof considered worthy of discussion. For instance, consider one British doctor's objection
to injectable heroin maintenance: "once injecting starts, many addicts
might be tempted to try other, more destructive drugs" (p. 204).
Americans may have a hard time picturing heroin as a stepping stone
to hard drugs. But if we are to fashion a more successful response to
heroin addiction, we should start looking more closely at the knowledge of the doctors and lawmakers of a nation with far more experience in the matter than we have.
Before America adopts anything like the British model of treating
addicts with doctor-prescribed heroin, we should first be very sure we
understand the implications of the changes that have occurred in that
model over the past twenty years. At the same time, the evidence is
much more convincing on heroin's role in the treatment of organic
illness; that issue can and should be dealt with separately. With Professor Trebach's help, a start has been made in arguing that both the
organically ill and the addict should have access to prescription heroin. But above all, The Heroin Solution is a balanced, exhaustively
researched contribution to the literature of heroin addiction and its
treatment.

